Atlas Trials

A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B

Clinical trial NCT03625102 · COMPLETED

Trial details

NCT number
NCT03625102
Sponsor
Golden Biotechnology Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HBV
Start date
2018-08-01
Primary completion
2023-06-16
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.